|
K. Johra, "Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy", Scientific Reports. 2.
|
|
K. Johra, "Whole-Exome Sequencing Reveals Migraine-Associated Novel Functional Variants in Arab Ancestry Females: A Pilot Study", Brain sciences. 3.
|
|
K. Johra, "FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies", JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS. 1.
|
|
K. Johra, "State-of-the-art tools to elucidate the therapeutic potential of TAT-peptide (TP) conjugated repurposing drug against SARS-CoV-2 spike glycoproteins", Current Pharmaceutical Design. Volume 28. 3.
|
|
K. Johra, "Molecular insight into the antiglycating and antiaggregating potential of ferulic acid with BSA", Monatshefte für Chemie/Chemical Monthly. Issue 153. 4.
|
|
K. Johra, "Development of gold nanoparticle-based biosensors for COVID-19 diagnosis", Beni-Suef University Journal ofBasic and Applied Sciences. Volume 11. 4.
|
|
K. Johra, "Human Monkeypox- An Update", Indo Global Journal of Pharmaceutical Sciences,. Volume 12.
|
